| Market Cap | 66.15M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -6.99M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -8.00% |
| Sales | 4.56M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -52.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -90.00% |
| Recommedations | - | Quick Ratio | 0.45 | Shares Outstanding | 6.13M | 52W Low Chg | 43.00% |
| Insider Own | 59.16% | ROA | -92.18% | Shares Float | 3.60M | Beta | 4.42 |
| Inst Own | - | ROE | -2,157.78% | Shares Shorted/Prior | -/- | Price | 0.06 |
| Gross Margin | 88.86% | Profit Margin | -153.28% | Avg. Volume | 1,605,831 | Target Price | - |
| Oper. Margin | -78.94% | Earnings Date | - | Volume | 3,096,260 | Change | 22.45% |
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. Its lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, and knee osteoarthritis. The company also provides Patient Pure X, an autologous blood-derived biologic technology, that is placed in the body for exosomes the cascade of cellular reprogramming and tissue repair. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Fort Lauderdale, Florida.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| MITRANI MARIA INES | Chief Science Office.. Chief Science Officer | Jun 21 | Sell | 0.14 | 50,000 | 7,000 | 116,707,890 | 06/21/21 |
| Shapiro George Craig | Chief Medical Office.. Chief Medical Officer | Jun 16 | Sell | 0.15 | 143,454 | 21,518 | 80,614,142 | 06/16/21 |
| MITRANI MARIA INES | Chief Science Office.. Chief Science Officer | Jun 16 | Sell | 0.15 | 150,000 | 22,500 | 116,757,890 | 06/16/21 |
| BOTHWELL IAN T | Chief Financial Offi.. Chief Financial Officer | Jun 16 | Sell | 0.15 | 190,000 | 28,500 | 148,068,726 | 06/16/21 |
| Mitrani Albert | President President | Jun 16 | Sell | 0.15 | 190,000 | 28,500 | 166,840,190 | 06/16/21 |
| MITRANI MARIA INES | Chief Science Office.. Chief Science Officer | Jun 11 | Sell | 0.14 | 215,110 | 30,115 | 116,907,890 | 06/11/21 |
| Mitrani Albert | President President | Jun 11 | Sell | 0.14 | 290,000 | 40,600 | 167,030,190 | 06/11/21 |
| BOTHWELL IAN T | Chief Financial Offi.. Chief Financial Officer | Jun 11 | Sell | 0.14 | 280,000 | 39,200 | 148,258,726 | 06/11/21 |
| Shapiro George Craig | Chief Medical Office.. Chief Medical Officer | Jun 11 | Sell | 0.15 | 150,000 | 22,500 | 80,757,596 | 06/11/21 |
| Shapiro George Craig | Chief Medical Office.. Chief Medical Officer | Jun 08 | Sell | 0.13 | 300,800 | 39,104 | 80,907,596 | 06/08/21 |
| MITRANI MARIA INES | Chief Science Office.. Chief Science Officer | Jun 08 | Sell | 0.13 | 300,000 | 39,000 | 117,123,000 | 06/08/21 |
| BOTHWELL IAN T | Chief Financial Offi.. Chief Financial Officer | Jun 08 | Sell | 0.14 | 300,000 | 42,000 | 148,538,726 | 06/08/21 |
| Mitrani Albert | President President | Jun 08 | Sell | 0.13 | 300,000 | 39,000 | 167,320,190 | 06/08/21 |
| BOTHWELL IAN T | Chief Financial Offi.. Chief Financial Officer | Jun 03 | Sell | 0.17 | 140,000 | 23,800 | 148,838,726 | 06/03/21 |
| Mitrani Albert | President President | Jun 03 | Sell | 0.18 | 140,000 | 25,200 | 167,620,190 | 06/03/21 |
| Shapiro George Craig | Chief Medical Office.. Chief Medical Officer | Jun 03 | Sell | 0.18 | 140,000 | 25,200 | 81,208,396 | 06/03/21 |
| MITRANI MARIA INES | Chief Science Office.. Chief Science Officer | Jun 03 | Sell | 0.17 | 140,000 | 23,800 | 117,423,000 | 06/03/21 |
| Shapiro George Craig | Chief Medical Office.. Chief Medical Officer | May 28 | Sell | 0.18 | 140,000 | 25,200 | 81,348,396 | 05/28/21 |
| MITRANI MARIA INES | Chief Science Office.. Chief Science Officer | May 28 | Sell | 0.18 | 190,000 | 34,200 | 117,563,000 | 05/28/21 |
| BOTHWELL IAN T | Chief Financial Offi.. Chief Financial Officer | May 28 | Sell | 0.18 | 190,000 | 34,200 | 148,978,726 | 05/28/21 |
| Mitrani Albert | President President | May 28 | Sell | 0.18 | 190,000 | 34,200 | 167,760,190 | 05/28/21 |
| Shapiro George Craig | Chief Medical Office.. Chief Medical Officer | May 25 | Sell | 0.19 | 156,504 | 29,736 | 81,488,396 | 05/25/21 |
| MITRANI MARIA INES | Chief Science Office.. Chief Science Officer | May 25 | Sell | 0.19 | 200,000 | 38,000 | 117,753,000 | 05/25/21 |
| BOTHWELL IAN T | Chief Financial Offi.. Chief Financial Officer | May 25 | Sell | 0.19 | 200,000 | 38,000 | 149,168,726 | 05/25/21 |
| Mitrani Albert | President President | May 25 | Sell | 0.19 | 200,000 | 38,000 | 167,950,190 | 05/25/21 |
| BOTHWELL IAN T | Chief Financial Offi.. Chief Financial Officer | May 17 | Sell | 0.23 | 175,000 | 40,250 | 149,570,000 | 05/17/21 |
| Mitrani Albert | President President | May 17 | Sell | 0.23 | 175,000 | 40,250 | 168,400,190 | 05/17/21 |
| MITRANI MARIA INES | Chief Science Office.. Chief Science Officer | May 17 | Sell | 0.23 | 175,000 | 40,250 | 118,205,000 | 05/17/21 |
| Shapiro George Craig | Chief Medical Office.. Chief Medical Officer | May 17 | Sell | 0.24 | 175,100 | 42,024 | 81,869,900 | 05/17/21 |
| Mitrani Albert | President President | May 12 | Sell | 0.29 | 175,000 | 50,750 | 168,575,190 | 05/12/21 |
| BOTHWELL IAN T | Chief Financial Offi.. Chief Financial Officer | May 12 | Sell | 0.3 | 150,000 | 45,000 | 149,745,000 | 05/12/21 |
| MITRANI MARIA INES | Chief Science Office.. Chief Science Officer | May 12 | Sell | 0.3 | 175,000 | 52,500 | 118,380,000 | 05/12/21 |
| Shapiro George Craig | Chief Medical Office.. Chief Medical Officer | May 12 | Sell | 0.29 | 150,100 | 43,529 | 82,045,000 | 05/12/21 |
| Mitrani Albert | President President | May 07 | Sell | 0.27 | 205,000 | 55,350 | 168,750,190 | 05/07/21 |